Similar to the previous study, COX-1/2-degrading PROTACs were specifically released in a cathepsin B-dependent manner, and the released PROTACs provoked COX-1/2 deficiency-associated prostaglandin E2 depletion, followed by the alteration of tumor immunosuppressive environments. This evidence concerns the gene CTSB and neoplasm.